Impact BioMedical Reveals U.S. Patent Issuance for 3F
Patent Issuance: Impact Biomedical has received U.S. patent No. 12,357,584 B2 for a method and composition to control infectious diseases using functional fragrances.
Technology Platform: The patent is developed within Impact Biomedical's 3F technology platform, focusing on compositions derived from plants and their fragrances.
Potential Applications: The patented compositions may serve as antibacterial or antiviral agents, expanding the company's capabilities in combating infectious diseases.
Patent Duration: This patent will remain valid until December 7, 2038, adding to Impact Biomedical's existing portfolio of insect repellent and anti-microbial patents.
Trade with 70% Backtested Accuracy
Analyst Views on IBO
About IBO
About the author
ZIM Integrated Shipping Shares Surge 7.6% on Acquisition Proposals
- Surge in Acquisition Proposals: ZIM Integrated Shipping has received multiple competitive acquisition proposals during its strategic review, with the board evaluating these offers to create significant value for shareholders, which is expected to enhance the company's market appeal.
- Stock Price Rebound: Following the announcement, ZIM's shares rose 7.6% in pre-market trading to $21.38, reflecting market optimism about the company's future prospects and potentially attracting more investor interest.
- Enhanced Strategic Value: By actively assessing acquisition proposals, ZIM not only strengthens its market position but also may achieve operational efficiencies through resource integration, thereby delivering higher returns to shareholders.
- Positive Market Reaction: The stock price increase indicates investor confidence in ZIM's potential acquisitions, which could further boost the company's competitiveness and market share in the shipping industry.
Impact Biomedical Inc (IBO) Announces Issuance of US Patent for 3F™
Patent Announcement: Impact Biomedical Inc. has received U.S. patent No. 12,357,584 B2 for a method to control infectious diseases using functional fragrances from its 3F™ technology platform.
Composition Details: The patented compositions include plant-derived constituents with antibacterial and antiviral properties, potentially effective against pathogens like E. coli, MRSA, influenza, and tuberculosis.
Market Potential: The global infectious disease market is expected to grow significantly, from $21.7 billion in 2024 to $34 billion by 2033, highlighting the demand for innovative healthcare solutions.
Company Commitment: IBO's CEO emphasized the company's dedication to developing unique technologies to address healthcare needs and is actively seeking partnerships to bring their 3F™ technology to market.
